St. Jude's, Amgen Settle Cancer Research Patent Row
St. Jude Children's Research Hospital Inc. on Wednesday ended a patent suit that accused Amgen Inc. of stealing patented DNA and nucleic acids material used to fight cancer and unlawfully licensing...To view the full article, register now.
Already a subscriber? Click here to view full article